A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The principal excitatory neurotransmitter in the vertebrate central nervous system, L-glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA (N-methyl-D-aspartate) and kainate. The development of selective pharmacological agents has led to a detailed understanding of the physiological and pathological roles of AMPA and NMDA receptors. In contrast, the lack of selective kainate receptor ligands has greatly hindered progress in understanding the roles of kainate receptors. Here we describe the effects of a potent and selective agonist, ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid), of the GluR5 subtype of kainate receptor. We have used these agents to show that kainate receptors, comprised of or containing GluR5 subunits, regulate synaptic inhibition in the hippocampus, an action that could contribute to the epileptogenic effects of kainate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hippocampus, exogenous kainate reduces the amplitude and Pr of evoked IPSCs onto CA1 pyramidal cells (208, 231, 734, 951) (however cf. with Refs. 231, 332).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [208]
Citations
Cites
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491 · cited 1×
“gif" NDATA ITEM> ]> The principal excitatory neurotransmitter in the vertebrate central nervous system, L -glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (α-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA ( N -methyl- D -aspartate) and kainat”
BackgroundMonaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Excitatory amino acid receptors in the vertebrate central nervous system.
Collingridge, G. L., & Lester, R. A. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00025-0 · Cited by 1,341
Self-citationBettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E. S., Moll, C., Borgmeyer, U., Hollmann, M., & Heinemann, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90213-y · Cited by 649 · cited 1×
“Here we describe the effects of a potent and selective agonist, ATPA (( RS )-2-amino-3-(3-hydroxy-5- tert -butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid),…”
BackgroundPartin, K. M., Patneau, D. K., Winters, C. A., Mayer, M. L., & Buonanno, A. (1993) · Neuron · doi:10.1016/0896-6273(93)90220-l · Cited by 583
Bettler, B., & Mulle, C. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00141-e · Cited by 456
Huettner, J. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90163-a · Cited by 420 · cited 1×
“Currents activated by kainate in acutely isolated dorsal root ganglion (DRG) neurons are thought to be mediated by GluR5 receptor”
BackgroundRegulation of glutamate release by presynaptic kainate receptors in the hippocampus
Chittajallu, R., Vignes, M., Dev, K. K., Barnes, J. M., Collingridge, G. L., & Henley, J. M. (1996) · Nature · doi:10.1038/379078a0 · Cited by 394 · cited 1×
“GYKI53655 (LY300168) was used to eliminate AMPA receptor-mediated synaptic transmission while preserving functional kainate receptor”
MethodSelf-citation
Research works printed but not linked: 2
- Seeburg, P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 14, 297–303 (1993).
- Bleakman, D. et al. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3 S, 4a R, 6 R, 8a R)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic-acid. Mol. Pharmacol. 49, 581–585 (1996).
Cited by
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
“…acid, (S)-5-iodowillardiine, and (4R)-isopentyl glutamate are potent agonists at homomeric GluK1 receptors but have little to no activity at GluK2 receptors (Clarke et al., 1997; Jane et al., 1997; Zhou et al., 1997; Small et al., 1998; Brehm et al., 2003; Bunch et al., 2009).”
BackgroundThe Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
“Two of the earliest of these are tetrazole-substituted decahydroisoquinolines, LY293558 and LY294486, which block homomeric GluR5 kainate receptors at 1 to 10 M but are inactive on GluR6 receptors (Bleakman et al., 1996a,b; Clarke et al., 1997).”
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
“ATPA, a substituted analogue of AMPA and (S)-5-iodowillardiine are potent, selective GluR5 agonists with low affinity at AMPA and GluR6 or GluR7-containing receptors (Clarke et al. 1997; Swanson et al. 1998; Alt et al. 2004).”
Metadata
- Authors
- Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D., & Bleakman, D.
- Affiliations
- University of Bristol (GB)
- Eli Lilly (United Kingdom) (GB)
- University of Edinburgh (GB)
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 599-603
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1637705010
- Cited by
- 416
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust
- Chinese Academy of Agricultural Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GluR5, kainate receptors, hippocampus, synaptic inhibition, atpA, glutamate receptors, epilepsy
- MeSH terms
- Animals, Cell Line, Cloning, Molecular, Hippocampus, Humans, Isoquinolines, Isoxazoles, Kainic Acid, Neural Inhibition, Propionates, Receptors, GABA-A, Synapses, Tetrazoles, Kainic Acid Receptors, Excitatory Amino Acid Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.